List of Tables
    Table 1. Neurometabolic Disorders Market Opportunities & Trends in Global Market
    Table 2. Neurometabolic Disorders Market Drivers in Global Market
    Table 3. Neurometabolic Disorders Market Restraints in Global Market
    Table 4. Key Players of Neurometabolic Disorders in Global Market
    Table 5. Top Neurometabolic Disorders Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Neurometabolic Disorders Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Neurometabolic Disorders Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Neurometabolic Disorders Product Type
    Table 9. List of Global Tier 1 Neurometabolic Disorders Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Neurometabolic Disorders Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Neurometabolic Disorders Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Neurometabolic Disorders Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Neurometabolic Disorders Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Neurometabolic Disorders Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Neurometabolic Disorders Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Neurometabolic Disorders Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Neurometabolic Disorders Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Neurometabolic Disorders Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Neurometabolic Disorders Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Neurometabolic Disorders Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Neurometabolic Disorders Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Neurometabolic Disorders Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Neurometabolic Disorders Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Neurometabolic Disorders Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Neurometabolic Disorders Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Neurometabolic Disorders Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Neurometabolic Disorders Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Neurometabolic Disorders Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Neurometabolic Disorders Revenue, (US$, Mn), 2023-2028
    Table 30. Amicus Therapeutics Corporate Summary
    Table 31. Amicus Therapeutics Neurometabolic Disorders Product Offerings
    Table 32. Amicus Therapeutics Neurometabolic Disorders Revenue (US$, Mn), (2017-2022)
    Table 33. ISU Abxis Corporate Summary
    Table 34. ISU Abxis Neurometabolic Disorders Product Offerings
    Table 35. ISU Abxis Neurometabolic Disorders Revenue (US$, Mn), (2017-2022)
    Table 36. JCR Pharmaceuticals Corporate Summary
    Table 37. JCR Pharmaceuticals Neurometabolic Disorders Product Offerings
    Table 38. JCR Pharmaceuticals Neurometabolic Disorders Revenue (US$, Mn), (2017-2022)
    Table 39. Biosidus Corporate Summary
    Table 40. Biosidus Neurometabolic Disorders Product Offerings
    Table 41. Biosidus Neurometabolic Disorders Revenue (US$, Mn), (2017-2022)
    Table 42. Greenovation Biotech Corporate Summary
    Table 43. Greenovation Biotech Neurometabolic Disorders Product Offerings
    Table 44. Greenovation Biotech Neurometabolic Disorders Revenue (US$, Mn), (2017-2022)
    Table 45. UAB Proforma Corporate Summary
    Table 46. UAB Proforma Neurometabolic Disorders Product Offerings
    Table 47. UAB Proforma Neurometabolic Disorders Revenue (US$, Mn), (2017-2022)
    Table 48. Dong-A Socio Group Corporate Summary
    Table 49. Dong-A Socio Group Neurometabolic Disorders Product Offerings
    Table 50. Dong-A Socio Group Neurometabolic Disorders Revenue (US$, Mn), (2017-2022)
    Table 51. ExSAR Corporation Corporate Summary
    Table 52. ExSAR Corporation Neurometabolic Disorders Product Offerings
    Table 53. ExSAR Corporation Neurometabolic Disorders Revenue (US$, Mn), (2017-2022)
    Table 54. Lixte Biotechnology Corporate Summary
    Table 55. Lixte Biotechnology Neurometabolic Disorders Product Offerings
    Table 56. Lixte Biotechnology Neurometabolic Disorders Revenue (US$, Mn), (2017-2022)
    Table 57. Neuraltus Pharmaceuticals Corporate Summary
    Table 58. Neuraltus Pharmaceuticals Neurometabolic Disorders Product Offerings
    Table 59. Neuraltus Pharmaceuticals Neurometabolic Disorders Revenue (US$, Mn), (2017-2022)
    Table 60. Protalix Corporate Summary
    Table 61. Protalix Neurometabolic Disorders Product Offerings
    Table 62. Protalix Neurometabolic Disorders Revenue (US$, Mn), (2017-2022)
    Table 63. Pharming Group Corporate Summary
    Table 64. Pharming Group Neurometabolic Disorders Product Offerings
    Table 65. Pharming Group Neurometabolic Disorders Revenue (US$, Mn), (2017-2022)
    Table 66. Protalix BioTherapeutics Corporate Summary
    Table 67. Protalix BioTherapeutics Neurometabolic Disorders Product Offerings
    Table 68. Protalix BioTherapeutics Neurometabolic Disorders Revenue (US$, Mn), (2017-2022)
    Table 69. Amicus Corporate Summary
    Table 70. Amicus Neurometabolic Disorders Product Offerings
    Table 71. Amicus Neurometabolic Disorders Revenue (US$, Mn), (2017-2022)
    Table 72. Biomarin Corporate Summary
    Table 73. Biomarin Neurometabolic Disorders Product Offerings
    Table 74. Biomarin Neurometabolic Disorders Revenue (US$, Mn), (2017-2022)
    Table 75. Genzyme Corporate Summary
    Table 76. Genzyme Neurometabolic Disorders Product Offerings
    Table 77. Genzyme Neurometabolic Disorders Revenue (US$, Mn), (2017-2022)
    Table 78. Shire Corporate Summary
    Table 79. Shire Neurometabolic Disorders Product Offerings
    Table 80. Shire Neurometabolic Disorders Revenue (US$, Mn), (2017-2022)
    Table 81. Greencross Corporate Summary
    Table 82. Greencross Neurometabolic Disorders Product Offerings
    Table 83. Greencross Neurometabolic Disorders Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Neurometabolic Disorders Segment by Type in 2021
    Figure 2. Neurometabolic Disorders Segment by Application in 2021
    Figure 3. Global Neurometabolic Disorders Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Neurometabolic Disorders Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Neurometabolic Disorders Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Neurometabolic Disorders Revenue in 2021
    Figure 8. By Type - Global Neurometabolic Disorders Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Neurometabolic Disorders Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Neurometabolic Disorders Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Neurometabolic Disorders Revenue Market Share, 2017-2028
    Figure 12. US Neurometabolic Disorders Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Neurometabolic Disorders Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Neurometabolic Disorders Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Neurometabolic Disorders Revenue Market Share, 2017-2028
    Figure 16. Germany Neurometabolic Disorders Revenue, (US$, Mn), 2017-2028
    Figure 17. France Neurometabolic Disorders Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Neurometabolic Disorders Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Neurometabolic Disorders Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Neurometabolic Disorders Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Neurometabolic Disorders Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Neurometabolic Disorders Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Neurometabolic Disorders Revenue Market Share, 2017-2028
    Figure 24. China Neurometabolic Disorders Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Neurometabolic Disorders Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Neurometabolic Disorders Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Neurometabolic Disorders Revenue, (US$, Mn), 2017-2028
    Figure 28. India Neurometabolic Disorders Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Neurometabolic Disorders Revenue Market Share, 2017-2028
    Figure 30. Brazil Neurometabolic Disorders Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Neurometabolic Disorders Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Neurometabolic Disorders Revenue Market Share, 2017-2028
    Figure 33. Turkey Neurometabolic Disorders Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Neurometabolic Disorders Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Neurometabolic Disorders Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Neurometabolic Disorders Revenue, (US$, Mn), 2017-2028
    Figure 37. Amicus Therapeutics Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. ISU Abxis Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. JCR Pharmaceuticals Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Biosidus Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Greenovation Biotech Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. UAB Proforma Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Dong-A Socio Group Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. ExSAR Corporation Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Lixte Biotechnology Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Neuraltus Pharmaceuticals Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Protalix Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Pharming Group Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Protalix BioTherapeutics Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. Amicus Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 51. Biomarin Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 52. Genzyme Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 53. Shire Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 54. Greencross Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2017-2022)